Moderna vs Qiagen: revenue, profit, margins and growth compared
Moderna brought in $1.9B of revenue in fiscal 2025, Qiagen $2.1B in fiscal 2025. Revenue changed by -39.9% at Moderna and +5.7% at Qiagen on the year before, so Qiagen grew faster. Moderna kept -145.2% of its revenue as net profit, Qiagen 20.3%. Free cash flow was -$2.1B at Moderna and $453.3M at Qiagen.
Fiscal years as each company reports them; the two may end in different months.
Questions about Moderna and Qiagen
Which is bigger by revenue, Moderna or Qiagen?
Qiagen is bigger by revenue: $2.1B in fiscal 2025, against $1.9B for Moderna in fiscal 2025.
Which keeps more of its revenue as profit, Moderna or Qiagen?
Moderna had a net margin of -145.2% in fiscal 2025; Qiagen had 20.3% in fiscal 2025.
Which grew revenue faster, Moderna or Qiagen?
In their latest fiscal years revenue changed by -39.9% at Moderna and +5.7% at Qiagen.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.